img

Post-pandemic Era-Global Anti-Infective Drug Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2034

Published on: 2024-01-04 | No of Pages : 334 | Industry : Pharma & Healthcare Research Center

Publisher : MRA | Format : PDF

Post-pandemic Era-Global Anti-Infective Drug Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2034

Summary

As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.

Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales.MRA published a report for global Anti-Infective Drug market in this environment.

In terms of revenue, this research report indicated that the global Anti-Infective Drug market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Anti-Infective Drug industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.

The Gilead Sciences aims at producing XX Anti-Infective Drug in 2020, with XX % production to take place in global market, GlaxoSmithKline accounts for a volume share of XX %.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Anti-Infective Drug Market byMRA Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Anti-Infective Drug Market?
Gilead Sciences
GlaxoSmithKline
Merck
Teva Pharmaceutical Industries
Johnson & Johnson
Boehringer Ingelheim
Pfizer
Mylan N.V.
Bristol-Myers Squibb
F. Hoffmann-La Roche
Shanghai Pharmaceuticals
...
Major Type of Anti-Infective Drug Covered inMRA report
Antibiotics
Antivirals
Antifungals
Others
Application Segments Covered inMRA Market
minor infections
complex surgery
immuno-suppressive treatments
Others

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Anti-Infective Drug Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Antibiotics -Product Introduction and Major Manufacturers
1.1.2 Antivirals -Product Introduction and Major Manufacturers
1.1.3 Antifungals -Product Introduction and Major Manufacturers
1.1.4 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Anti-Infective Drug Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
3.1 China Anti-Infective Drug Market
3.1.1 Top Companies leading Anti-Infective Drug Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Anti-Infective Drug Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Anti-Infective Drug Market
3.2.1 Top Companies leading Anti-Infective Drug Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Anti-Infective Drug Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Anti-Infective Drug Market
3.3.1 Top Companies leading Anti-Infective Drug Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Anti-Infective Drug Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Anti-Infective Drug Market
3.4.1 Top Companies leading Anti-Infective Drug Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Anti-Infective Drug Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Anti-Infective Drug Market
3.5.1 Top Companies leading Anti-Infective Drug Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Anti-Infective Drug Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Anti-Infective Drug Market
3.6.1 Top Companies leading Anti-Infective Drug Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Anti-Infective Drug Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Anti-Infective Drug Market
3.7.1 Top Companies leading Anti-Infective Drug Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Anti-Infective Drug Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
4.1 Anti-Infective Drug Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Anti-Infective Drug Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
5.1 Global Anti-Infective Drug Sales and Growth Rate (2021-2026)
5.2 Global Anti-Infective Drug Sales Value and Growth Rate (2021-2026)

6 Anti-Infective Drug Competitive Analysis
6.1 Gilead Sciences
6.1.1 Gilead Sciences Company Profiles
6.1.2 Gilead Sciences Product Introduction
6.1.3 Gilead Sciences Anti-Infective Drug Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Company Profiles
6.2.2 GlaxoSmithKline Product Introduction
6.2.3 GlaxoSmithKline Anti-Infective Drug Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 Merck
6.3.1 Merck Company Profiles
6.3.2 Merck Product Introduction
6.3.3 Merck Anti-Infective Drug Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 Teva Pharmaceutical Industries
6.4.1 Teva Pharmaceutical Industries Company Profiles
6.4.2 Teva Pharmaceutical Industries Product Introduction
6.4.3 Teva Pharmaceutical Industries Anti-Infective Drug Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Company Profiles
6.5.2 Johnson & Johnson Product Introduction
6.5.3 Johnson & Johnson Anti-Infective Drug Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Company Profiles
6.6.2 Boehringer Ingelheim Product Introduction
6.6.3 Boehringer Ingelheim Anti-Infective Drug Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Pfizer
6.7.1 Pfizer Company Profiles
6.7.2 Pfizer Product Introduction
6.7.3 Pfizer Anti-Infective Drug Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Mylan N.V.
6.8.1 Mylan N.V. Company Profiles
6.8.2 Mylan N.V. Product Introduction
6.8.3 Mylan N.V. Anti-Infective Drug Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 Bristol-Myers Squibb
6.9.1 Bristol-Myers Squibb Company Profiles
6.9.2 Bristol-Myers Squibb Product Introduction
6.9.3 Bristol-Myers Squibb Anti-Infective Drug Production, Revenue (2015-2020)
6.9.4 SWOT Analysis
6.10 F. Hoffmann-La Roche
6.10.1 F. Hoffmann-La Roche Company Profiles
6.10.2 F. Hoffmann-La Roche Product Introduction
6.10.3 F. Hoffmann-La Roche Anti-Infective Drug Production, Revenue (2015-2020)
6.10.4 SWOT Analysis
6.11 Shanghai Pharmaceuticals
7 Conclusion


List of Figure

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Anti-Infective Drug Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Anti-Infective Drug Sales (K Unit) by Type (2015-2026)
Figure Global Anti-Infective Drug Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Anti-Infective Drug Sales Market Share (%) by Type (2019 -2020)
Table Global Anti-Infective Drug Sales Value (Million USD) by Type (2015-2026)
Figure Global Anti-Infective Drug Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Anti-Infective Drug Sales Value Market Share (%) by Type (2019-2020)
Table Global Anti-Infective Drug Sales (K Unit) by Application (2015-2026)
Table China Anti-Infective Drug Sales (K Unit) of Major Company (2015-2020)
Table China Anti-Infective Drug Sales Market Share of Major Company (2015-2020)
Table China Anti-Infective Drug Sales Value (Million USD) of Major Company (2015-2020)
Figure China Anti-Infective Drug Sales Value (Million USD) and Growth Rate (2015-2020)
Table China Anti-Infective Drug Sales Value Share of Major Company (2015-2020)
Table China Anti-Infective Drug Price (USD/Unit), by Type (2019-2020)
Table China Anti-Infective Drug Sales (Unit) by Type (2015-2026)
Figure China Anti-Infective Drug Sales (Unit) by Type (2015-2026)
Table EU Anti-Infective Drug Sales (K Unit) of Major Company (2015-2020)
Table EU Anti-Infective Drug Sales Market Share of Major Company (2015-2020)
Table EU Anti-Infective Drug Sales Value (Million USD) of Major Company (2015-2020)
Figure EU Anti-Infective Drug Sales Value (Million USD) and Growth Rate (2015-2020)
Table EU Anti-Infective Drug Sales Value Share of Major Company (2015-2020)
Table EU Anti-Infective Drug Price (USD/Unit), by Type (2019-2020)
Table EU Anti-Infective Drug Sales (Unit) by Type (2015-2026)
Figure EU Anti-Infective Drug Sales (Unit) by Type (2015-2026)
Table USA Anti-Infective Drug Sales (K Unit) of Major Company (2015-2020)
Table USA Anti-Infective Drug Sales Market Share of Major Company (2015-2020)
Table USA Anti-Infective Drug Sales Value (Million USD) of Major Company (2015-2020)
Figure USA Anti-Infective Drug Sales Value (Million USD) and Growth Rate (2015-2020)
Table USA Anti-Infective Drug Sales Value Share of Major Company (2015-2020)
Table USA Anti-Infective Drug Price (USD/Unit), by Type (2019-2020)
Table USA Anti-Infective Drug Sales (Unit) by Type (2015-2026)
Figure USA Anti-Infective Drug Sales (Unit) by Type (2015-2026)
Table Japan Anti-Infective Drug Sales (K Unit) of Major Company (2015-2020)
Table Japan Anti-Infective Drug Sales Market Share of Major Company (2015-2020)
Table Japan Anti-Infective Drug Sales Value (Million USD) of Major Company (2015-2020)
Figure Japan Anti-Infective Drug Sales Value (Million USD) and Growth Rate (2015-2020)
Table Japan Anti-Infective Drug Sales Value Share of Major Company (2015-2020)
Table Japan Anti-Infective Drug Price (USD/Unit), by Type (2019-2020)
Table Japan Anti-Infective Drug Sales (Unit) by Type (2015-2026)
Figure Japan Anti-Infective Drug Sales (Unit) by Type (2015-2026)
Table India Anti-Infective Drug Sales (K Unit) of Major Company (2015-2020)
Table India Anti-Infective Drug Sales Market Share of Major Company (2015-2020)
Table India Anti-Infective Drug Sales Value (Million USD) of Major Company (2015-2020)
Figure India Anti-Infective Drug Sales Value (Million USD) and Growth Rate (2015-2020)
Table India Anti-Infective Drug Sales Value Share of Major Company (2015-2020)
Table India Anti-Infective Drug Price (USD/Unit), by Type (2019-2020)
Table India Anti-Infective Drug Sales (Unit) by Type (2015-2026)
Figure India Anti-Infective Drug Sales (Unit) by Type (2015-2026)
Table Southeast Asia Anti-Infective Drug Sales (K Unit) of Major Company (2015-2020)
Table Southeast Asia Anti-Infective Drug Sales Market Share of Major Company (2015-2020)
Table Southeast Asia Anti-Infective Drug Sales Value (Million USD) of Major Company (2015-2020)
Figure Southeast Asia Anti-Infective Drug Sales Value (Million USD) and Growth Rate (2015-2020)
Table Southeast Asia Anti-Infective Drug Sales Value Share of Major Company (2015-2020)
Table Southeast Asia Anti-Infective Drug Price (USD/Unit), by Type (2019-2020)
Table Southeast Asia Anti-Infective Drug Sales (Unit) by Type (2015-2026)
Figure Southeast Asia Anti-Infective Drug Sales (Unit) by Type (2015-2026)
Table South America Anti-Infective Drug Sales (K Unit) of Major Company (2015-2020)
Table South America Anti-Infective Drug Sales Market Share of Major Company (2015-2020)
Table South America Anti-Infective Drug Sales Value (Million USD) of Major Company (2015-2020)
Figure South America Anti-Infective Drug Sales Value (Million USD) and Growth Rate (2015-2020)
Table South America Anti-Infective Drug Sales Value Share of Major Company (2015-2020)
Table South America Anti-Infective Drug Price (USD/Unit), by Type (2019-2020)
Table South America Anti-Infective Drug Sales (Unit) by Type (2015-2026)
Figure South America Anti-Infective Drug Sales (Unit) by Type (2015-2026)
Figure Value Chain Structure of Anti-Infective Drug
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Anti-Infective Drug
Figure Cost Structure of Anti-Infective Drug in 2020
Table Distributors/Traders List
Table Regional Market Sales (K Unit) (2021-2026)
Table Regional Market Sales Share (2021-2026)
Figure Global Anti-Infective Drug Sales (Unit), Growth Rate & Market Share (2021-2026)
Table Regional Market Sales Value (Million USD) (2021-2026)
Table Regional Market Sales Value Share (2021-2026)
Figure Global Anti-Infective Drug Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table Gilead Sciences Profiles
Table Gilead Sciences Anti-Infective Drug Product Introduction
Table Gilead Sciences Anti-Infective Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Gilead Sciences SWOT Analysis
Table GlaxoSmithKline Profiles
Table GlaxoSmithKline Anti-Infective Drug Product Introduction
Table GlaxoSmithKline Anti-Infective Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure GlaxoSmithKline SWOT Analysis
Table Merck Profiles
Table Merck Anti-Infective Drug Product Introduction
Table Merck Anti-Infective Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Merck SWOT Analysis
Table Teva Pharmaceutical Industries Profiles
Table Teva Pharmaceutical Industries Anti-Infective Drug Product Introduction
Table Teva Pharmaceutical Industries Anti-Infective Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Teva Pharmaceutical Industries SWOT Analysis
Table Johnson & Johnson Profiles
Table Johnson & Johnson Anti-Infective Drug Product Introduction
Table Johnson & Johnson Anti-Infective Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Johnson & Johnson SWOT Analysis
Table Boehringer Ingelheim Profiles
Table Boehringer Ingelheim Anti-Infective Drug Product Introduction
Table Boehringer Ingelheim Anti-Infective Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Boehringer Ingelheim SWOT Analysis
Table Pfizer Profiles
Table Pfizer Anti-Infective Drug Product Introduction
Table Pfizer Anti-Infective Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Pfizer SWOT Analysis
Table Mylan N.V. Profiles
Table Mylan N.V. Anti-Infective Drug Product Introduction
Table Mylan N.V. Anti-Infective Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Mylan N.V. SWOT Analysis
Table Bristol-Myers Squibb Profiles
Table Bristol-Myers Squibb Anti-Infective Drug Product Introduction
Table Bristol-Myers Squibb Anti-Infective Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure Bristol-Myers Squibb SWOT Analysis
Table F. Hoffmann-La Roche Profiles
Table F. Hoffmann-La Roche Anti-Infective Drug Product Introduction
Table F. Hoffmann-La Roche Anti-Infective Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Figure F. Hoffmann-La Roche SWOT Analysis
Table Shanghai Pharmaceuticals Profiles
Table Shanghai Pharmaceuticals Anti-Infective Drug Product Introduction
Table Shanghai Pharmaceuticals Anti-Infective Drug Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)

Select User License

$2950 Single Licence
$4500 Enterprise Licence
$7000 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries